Evidence map›Paper›PMID 28128768›Full record

ArticleJournal of Alzheimer's disease : JAD2017

Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.

Raffaele Ferrari, Mario Grassi, Francesca Graziano, Fernando Palluzzi, Silvana Archetti, Elisa Bonomi, Amalia C Bruni, Raffaele G Maletta, Livia Bernardi, Chiara Cupidi and 21 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. TheInternational journal of molecular sciences · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 11 institutions in 3 countries.

Raffaele FerrariDepartment of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Mario GrassiDepartment of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy.
Francesca GrazianoDepartment of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy.
Fernando PalluzziDepartment of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy.
Silvana ArchettiDepartment of Laboratories, III Laboratory of Analysis, Brescia Hospital, Brescia, Italy.
Elisa BonomiDepartment of Clinical and Experimental Science, Neurology Unit, University of Brescia, Italy.
Amalia C BruniNeurogenetic Regional Centre ASPCZ Lamezia Terme, Lamezia Terme, Italy.
Raffaele G MalettaNeurogenetic Regional Centre ASPCZ Lamezia Terme, Lamezia Terme, Italy.
Livia BernardiNeurogenetic Regional Centre ASPCZ Lamezia Terme, Lamezia Terme, Italy.
Chiara CupidiNeurogenetic Regional Centre ASPCZ Lamezia Terme, Lamezia Terme, Italy.
Rosanna ColaoNeurogenetic Regional Centre ASPCZ Lamezia Terme, Lamezia Terme, Italy.
Innocenzo RaineroDepartment of Neuroscience, Neurology I, University of Torino and Cittá della Salute e della Scienza di Torino, Turin, Italy.
Elisa RubinoDepartment of Neuroscience, Neurology I, University of Torino and Cittá della Salute e della Scienza di Torino, Turin, Italy.
Lorenzo PinessiDepartment of Neuroscience, Neurology I, University of Torino and Cittá della Salute e della Scienza di Torino, Turin, Italy.
Daniela GalimbertiDepartment of Pathophysiology and Transplantation, Neurology Unit, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Policlinico, Milan, Italy.
Elio ScarpiniDepartment of Pathophysiology and Transplantation, Neurology Unit, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Policlinico, Milan, Italy.
Maria SerpenteDepartment of Pathophysiology and Transplantation, Neurology Unit, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Policlinico, Milan, Italy.
Benedetta NacmiasDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Irene PiaceriDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Silvia BagnoliDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Giacomina RossiDivision of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Giorgio GiacconeDivision of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Fabrizio TagliaviniDivision of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Luisa BenussiMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Giuliano BinettiMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Roberta GhidoniMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Andrew SingletonLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
John HardyDepartment of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Parastoo MomeniDepartment of Internal Medicine, Laboratory of Neurogenetics, Texas Tech University Health Science Center, Lubbock, TX, USA.
Alessandro PadovaniDepartment of Clinical and Experimental Science, Neurology Unit, University of Brescia, Italy.
Barbara BorroniDepartment of Clinical and Experimental Science, Neurology Unit, University of Brescia, Italy.
University of Brescia · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITCentro San Giovanni di Dio Fatebenefratelli · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITUniversity of Florence · ITUniversity of Pavia · ITUniversity College London · GBUniversity of Milan · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITNational Institute on Aging · USTexas Tech University · US

Funding

Genetic Analysis Of Non- Alzheimer's disease DementiasZIAAG000951 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2020
$5.6M
Genetic Analysis Of Non-Alzheimer DementiasZ01AG000951 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2002 to 2008
$647k
Intramural NIH HHS Z01 AG000951Intramural NIH HHS Z99 AG999999Medical Research Council G0701075Medical Research Council G0901254Medical Research Council G1001253Medical Research Council MR/J004758/1Medical Research Council MR/K01417X/1Medical Research Council MR/L501542/1Parkinson's UK G-1307
6 · The paper itself

Abstract

In frontotemporal dementia (FTD), age at disease onset (AAO) is unpredictable in both early and late-onset cases; AAO variability is found even in autosomal dominant FTD. The present study was aimed at identifying genetic modifiers modulating AAO in a large cohort of Italian FTD patients. We conducted an association analysis on 411 FTD patients, belonging to 7 Italian Centers, and for whom AAO was available. Population structure was evaluated by principal component analysis to infer continuous axes of genetic variation, and single linear regression models were applied. A genetic score (GS) was calculated on the basis of suggestive single nucleotide polymorphisms (SNPs) found by association analyses. GS showed genome-wide significant slope decrease by -3.86 (95% CI: -4.64 to -3.07, p < 2×10-16) per standard deviation of the GS for 6 SNPs mapping to genes involved in neuronal development and signaling, axonal myelinization, and glutamatergic/GABA neurotransmission. An increase of the GS was associated with a decrease of the AAO. Our data indicate that there is indeed a genetic component that underpins and modulates up to 14.5% of variability of AAO in Italian FTD. Future studies on genetic modifiers in FTD are warranted.

Indexed as

Genetic LociAdultAgedAged, 80 and overAge of OnsetCohort StudiesFrontotemporal DementiaGenetic Association StudiesHumansItalyLinear ModelsMiddle AgedPolymorphism, Single NucleotidePrincipal Component AnalysisAge at onsetfrontotemporal dementiaGWASpolymorphism

Identifiers

PMID28128768
PMCPMC6178215
OpenAlexW2581204327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.